SCHEMBL24671111

SCHEMBL24671111

CCc1cccc2c1C(=O)N(C(C)C)C2=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.45
DPP4 P27487 2/20 0.45
TDP1 Q9NUW8 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
USP2 O75604 2/20 0.39
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CASP1 P29466 1/20 0.37
BRCA1 P38398 1/20 0.37
CASP7 P55210 1/20 0.37
LMNA P02545 2/20 0.36
TYMS P04818 1/20 0.36
PDK2 Q15119 1/20 0.36
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
CYP1B1 Q16678 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670228 0.89 ANPEP (0.39) ANPEPDPP4TDP1CRHBPCRHR2
SCHEMBL10925232 0.87 ANPEP (0.43) ANPEPDPP4TDP1CRHBPCRHR2
Hydrochloric Acid SCHEMBL10982278 0.85 ANPEP (0.42) ANPEPDPP4TDP1CRHBPCRHR2
SCHEMBL30805797 0.84 ANPEP (0.44) ANPEPDPP4TDP1KMT2ACASP1
SCHEMBL31259865 0.79 DPP4 (0.51) DPP4USP2KMT2AMEN1LMNA
SCHEMBL5326245 0.79 DPP4 (0.51) DPP4USP2KMT2AMEN1LMNA
SCHEMBL12420865 0.79 DPP4 (0.47) DPP4USP2KMT2AMEN1TYMS
SCHEMBL1040431 0.77 DPP4 (0.49) ANPEPDPP4TDP1USP2KMT2A
SCHEMBL22041008 0.77 MAPT (0.43) ANPEPDPP4TDP1USP2KMT2A
SCHEMBL28646985 0.77 KMT2A (0.43) TDP1USP2KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed